CiteFacts · FDA Drug Shortages · FDA source
Hydroxocobalamin Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| BTG International Inc. | Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | Limited Availability | 08/17/2026 |
| Teva Pharmaceuticals USA, Inc. | Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Unavailable | 08/04/2026 |
Source facts
Grouped generic ingredient: Hydroxocobalamin Injection · 2 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Other
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.